Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection☆ | Zendy

Stefan Watzka | Zendy; Irene Rauscher-Pötsch | Zendy; Elisabeth Stubenberger | Zendy; V. G. Getman | Zendy; Ulrike Setinek | Zendy; Martin Tötsch | Zendy; Ulrike Pötschger | Zendy; Michael Müller | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection☆

Author(s) -

Stefan Watzka,

Irene Rauscher-Pötsch,

Elisabeth Stubenberger,

V. G. Getman,

Ulrike Setinek,

Martin Tötsch,

Ulrike Pötschger,

Michael Müller

Publication year - 2010

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1016/j.ejcts.2010.02.006

Subject(s) - integrin linked kinase , medicine , adenocarcinoma , immunohistochemistry , lung cancer , tissue microarray , pathology , histology , cancer , oncology , cell cycle , cyclin dependent kinase 2

Increased immunoreactivity of integrin-linked kinase (ILK) in the primary tumour is an adverse prognostic factor in a variety of preclinical and clinical models of human cancer. Here, we investigate the relationship between ILK immunoreactivity in primary non-small-cell lung cancer (NSCLC) and the survival after curative lung resection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research